Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07360418 · ClinicalTrials.gov registry record
Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.
A clinical trial of Diabetic Foot Ulcer and Ulcer, sponsored by Applied Biologics.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT07360418 is a study of Diabetic Foot Ulcer and Ulcer that is actively recruiting participants, run by Applied Biologics. The registered enrollment target is 50 participants, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT07360418, a study of Diabetic Foot Ulcer and Ulcer, is actively recruiting participants, sponsored by Applied Biologics.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Prospective long-term follow-up on durability of closure evaluated by photographic and thermal scanning.
Conditions Studied
Interventions
- OTHER Blue Drop Foot Scanner
Study Locations (1)
Michigan
- Detroit Foot and Ankle - Clinton Township
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2025-10-16 |
| Est. Completion | 2027-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07360418
The ClinicalTrials.gov registry entry for NCT07360418 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 254-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (80% lower). The listed sponsor is Applied Biologics, which has 4 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Blue Drop Foot Scanner is the first listed.
NCT07360418 reports 1 study location spanning 1 distinct geographic area - top geographies include Michigan.
Frequently Asked Questions
What is clinical trial NCT07360418 about?
NCT07360418 is a clinical study titled "Evaluating the Durability of Closure for Diabetic Foot Ulcers Following a Randomized, Controlled, Modified Platform Trial.". Prospective long-term follow-up on durability of closure evaluated by photographic and thermal scanning.
What is the current status of trial NCT07360418?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2025-10-16. Estimated completion is 2027-10.
What conditions does trial NCT07360418 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer, Ulcer, Foot Ulcer Chronic, Diabetic Foot Ulcers (DFU).
What interventions are being tested in trial NCT07360418?
The interventions under investigation include: Blue Drop Foot Scanner (OTHER).
Who is sponsoring clinical trial NCT07360418?
This trial is sponsored by Applied Biologics, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07360418 being conducted?
This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Randomized Evaluation of Nonhealing Diabetic Foot Ulcers With Exclusive Wound Therapy
RECRUITING · Phase 4
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
Evaluate Use of Tropocells(R) Autologous Platelet-rich Fibrin (PRF) for Wagner Grade 1 and Grade 2, Mild to Mod Neuroischemic Plantar Diabetic Foot Ulcer Wound Care.
RECRUITING · Phase 2
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.